Originalkatalog | Verfügbarkeit prüfen

248P The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE registry

Meegdes, M., Geurts, S.M.E., Erdkamp, F.L.G., Dercksen, M.W., Vriens, B.E.P.J., Aaldering, K., Pepels, M.J.A.E., Winkel, L.V.D., Teeuwen, N.J.A., De Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Annals of Oncology ; volume 32, page S468-S469 ; ISSN 0923-7534;
2021

Originalkatalog | Verfügbarkeit prüfen

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry

Meegdes, M., Geurts, S.M.E., Erdkamp, F.L.G., Dercksen, M.W., Vriens, B.E.P.J., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.M.H., Teeuwen, N.J.A., Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022

Originalkatalog | Verfügbarkeit prüfen

180P A doubling in overall survival of patients with de novo HER2+ advanced breast cancer in the Netherlands

Geurts, S.M.E., Ibragimova, K., Meegdes, M., Erdkamp, F.L.G., Heijns, J.B., Tol, J., Vriens, B.E.P.J., Dercksen, W., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.V.D., Peters, N., van de Wouw, A.J., Hochstenbach, A., De Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Annals of Oncology ; volume 33, page S210 ; ISSN 0923-7534;
2022